STOCK TITAN

Nocturne Acquisition Corporation - $MBTCU STOCK NEWS

Welcome to our dedicated page for Nocturne Acquisition Corporation news (Ticker: $MBTCU), a resource for investors and traders seeking the latest updates and insights on Nocturne Acquisition Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Nocturne Acquisition Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Nocturne Acquisition Corporation's position in the market.

Rhea-AI Summary
Nocturne Acquisition (NASDAQ:MBTCU) announced the termination and liquidation of its Trust Account due to the inability to complete a business combination with Cognos Therapeutics, Inc. The Company will redeem all outstanding public shares at a per-share price of approximately $11.79.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Nocturne Acquisition Corp. (NASDAQ:MBTCU) has postponed its Extraordinary General Meeting for the proposed business combination with Cognos Therapeutics, Inc. The meeting will now be held virtually on April 2, 2024. Shareholders can still vote on the proposals, with no changes made, and the record date remains December 29, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Nocturne Acquisition Corp. (NASDAQ:MBTCU) has postponed the Extraordinary General Meeting to vote on the business combination with Cognos Therapeutics, Inc. The meeting will now be held virtually on March 19, 2024, with no changes in the proposals. Shareholders can still vote even if they have sold their shares, and the deadline for redemption rights has been extended.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Nocturne Acquisition Corp. (NASDAQ:MBTCU) has announced a second postponement of the Extraordinary General Meeting for shareholders to vote on the proposed business combination with Cognos Therapeutics, Inc. The meeting, originally scheduled for January 30, 2024, has been rescheduled to February 27, 2024, and will be held virtually. Shareholders are encouraged to continue to solicit proxies, and the record date for the meeting remains December 29, 2023. The deadline for shareholders to exercise their redemption rights has been extended to two business days prior to the meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Nocturne Acquisition Corp. (NASDAQ:MBTCU) has postponed the Extraordinary General Meeting for the proposed business combination with Cognos Therapeutics, Inc. to February 6, 2024. The meeting will be held virtually, and shareholders can continue to vote on the proposals. The record date for the meeting remains December 29, 2023, and shareholders who have already voted need not take any action. The deadline for redemption rights has been extended to two business days before the meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
23.5%
Tags
-
Rhea-AI Summary
Nocturne Acquisition Corporation (NASDAQ:MBTC) has submitted a registration statement to the SEC for a proposed business combination with Cognos Therapeutics, Inc. The combination aims to accelerate the research and advancement of Cognos' implantable drug delivery pump for the treatment of brain cancers and neurological diseases. The transaction is expected to close in Q4 2023 and the combined company will be renamed Cognos Therapeutics Holdings, Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.47%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Nocturne Acquisition Corporation

Nasdaq:MBTCU

MBTCU Rankings

MBTCU Stock Data

1.70M
0.01%
Shell Companies
Financial Services
Link
United States
Wilmington

About MBTCU

led by experienced technology and crypto operators, nocturne will leverage its deep industry expertise and vast global network to identify unique, public ready opportunities. our mission is to partner with a crypto or ai tech company that will enable the next frontier of innovation.